I together with the large dose in man (10-15 g. per day) might indicate that the drug undergoes in vivo conversion to an active material. We particularly wished to test the suggestion that o, p'-DDD might undergo in vivo hydroxylation and rearrangement to stilbenes such as I1 and I11 which may be